Ardais has named Gregory Phelps CEO, the company said Jan. 20.

Phelps, 53, comes to Ardais from Dyax, where he was vice chairman and was responsible for corporate development.

“Greg is well known as an industry leader with strong business management skills, extensive operations experience, knowledge of R&D management, and expertise in the development of new products and new businesses on a global scale,” said Ardais’ Chairman Jeffrey Otten.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.